Latin America pairs the inputs for frontier science with a market that has chronically underpriced them. The problems and the opportunities are two sides of the same coin. The report combines a database of 2,566 deep tech ventures with more than 100 interviews and five roundtables to map the ecosystem and to chart a path from the "LATAM Discount" to fair value.
865kSTEM researchers, but under 1% work in deep tech: a 100× runway of untapped talent
72%Gross average return on LATAM biotech startups, 2015–2023 (SOSV/IndieBio)
219%YoY deep tech funding growth in 2024, the fastest-growing sector
20×Projected deep tech ecosystem growth by 2032 (IDB)
The report groups its 20 recommendations into three arcs: what companies must do to become investable (Market Readiness), what unlocks investor confidence (Investor Readiness), and the regional coalition that ties it together, plus five further-research initiatives. The through-line is that the discount is a temporary mispricing driven by solvable structural factors, not permanently inferior fundamentals.